MARIA BUKOWSKYJ, M.D.; KANJI NAKATSU, Ph.D.; PETER W. MUNT, M.D.
▸Requests for reprints should be addressed to Maria Bukowskyj, M.D.; Division of Respiratory Medicine, Department of Medicine, Queen's University; Kingston, ON K7L 3N6, Canada.
BUKOWSKYJ M., NAKATSU K., MUNT P.; Theophylline Reassessed. Ann Intern Med. 1984;101:63-73. doi: 10.7326/0003-4819-101-1-63
Download citation file:
Published: Ann Intern Med. 1984;101(1):63-73.
Advances have recently been made in understanding the pharmacokinetics of theophylline. To correlate the new knowledge of theophylline pharmacokinetics with the drug's current status in therapy, we have critically reviewed the relevant investigations of the last 5 years. We consider data on its presumed mechanisms of action, factors affecting its clearance, its use in pregnancy, treatment of overdoses, and important drug interactions. Theophylline clearance is decreased by concomitant use of erythromycin, cimetidine, high-dose allopurinol, oral contraceptives, and caffeine. Clearance is increased by concomitant use of phenobarbital and phenytoin. Newly discovered actions of theophylline include dose-dependent improvement of diaphragmatic contractility, augmentation of ventilatory response to hypoxia, and sleep disturbances (especially with high-dose treatments). Points clinically relevant to the daily use of theophylline derivatives and the importance of sustained-release preparations are discussed. Theophylline continues to play a major role in therapy for reactive airways disease.
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Emergency Medicine, Pulmonary/Critical Care, Rheumatology, Gout, Sleep Disorders.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only